[4] Macdonald JB,Macdonald B,Golitz LE,et al.Cutaneous
a d v e r s e e ff e c t s o f t a rg e t e d t h e r a p i e s : P a r t I :
Inhibitors of the cellular membrane[J].J Am Acad
Dermatol,2015,72(2):203-220.
[5] Lisi P,Bellini V,Bianchi L.The Epidermal Growth
Factor Receptor Inhibitor-Related Skin Toxicity Index
(EGFRISTI):a new tool for grading and managing skin
adverse reactions to epidermal growth factor receptor
inhibitors[J].Oncology.2014.87(5):311-319.
[6] Macdonald JB, Macdonald B, Golitz LE,et al.Cutaneous
adverse effects of targeted therapies:Part II:Inhibitors of
intracellular molecular signaling pathways[J].J Am Acad
Dermatol,2015,72(2):221-238.
